BY ALBERT RONNING-ANDERSSON
-
Novo Nordisk expects Ozempic supply issues in fourth quarter
The Danish pharmaceutical firm is advising medical professionals to restrict the startup of brand-new people on the diabetic issues medicine Ozempic up until the supply circumstanc…
-
Eli Lilly sells migraine treatment rights in USD 22.5m deal
Organon has actually gotten the civil liberties to offer Eli Lilly’s migraine headache medication on 11 added markets. The events got to an arrangement on European civil libe…
-
Novo Nordisk Foundation donates millions to fight antibiotic resistance
As a part of a brand new collaboration with a UK charity, the Novo Nordisk Basis is donating DKK 3m to scale back antibiotic resistance in low- and middle-income nations.
-
Eight life science companies accepted into BII program
The BII program Endeavor Laboratory gives approximately DKK 13.4 m in financial backing and supplies suggestions approximately the factor of evidence of principle.
-
ALK’s CFO is confident about ambitious 2025 target
To sustain the 2025 passion, ALK introduced a variety of modifications in March, consisting of the decrease of 125 placements in the firm.
-
Gubra reveals timeline for obesity drug candidate
By the end of 2024, the Danish biotech business anticipates to have information from the very first component of a Stage I test screening the medicine prospect gubamy for the thera…
-
WSA ramps up IPO preparations
Despite The Fact That the CFO of the globe’s third-largest listening devices firm, WA Audiology, will not divulge when she means on bringing the firm public, a great deal of …
-
Demant acquires GN retail chain
The procurement of the retail chain Dansk Hørecenter from competing GN, with a price of DKK 100m (USD 14.9 m), rates amongst the bigger bargains for Demant in the retail field.
-
Novo Nordisk opens festival space for 23,000 employees for summer party
On Friday, Novo Nordisk is organizing a summer season celebration at Dyrskuepladsen in Roskilde, where the pop celebrity Mø is amongst the doing musicians.
-
Biotech veterans join forces with hospital researcher to take new approach to obesity
Incipiam Pharma is dealing with a brand-new system of activity in weight problems therapy, backed by scientist Tora Henriksen and seasoned faces from Embark Biotech, which Novo got…